SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Alternative Medicine/Health

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who started this subject8/10/2001 3:43:48 AM
From: sim1   of 357
 
Vitamins May Blunt Cholesterol Drugs

By ALEX LYDA
Associated Press Writer

August 9 2001

DALLAS -- Extra doses of vitamins such as C and E may blunt some benefits of widely prescribed cholesterol-lowering drugs, a new study concludes.

Some research suggests that the so-called antioxidant vitamins, intended to offset the harmful effects of oxygen, may help keep arteries healthy, while other reports have disputed this idea.

The latest study compared patients with coronary artery disease who were taking a mix of antioxidant vitamins and drugs to those who were taking drugs alone. The study used the vitamin niacin and the drug Zocor, which lowers artery-clogging LDL cholesterol while increasing beneficial HDL cholesterol.

It found that the volunteers' HDL levels failed to rise as much as expected when they mixed the vitamins with their cholesterol drugs.

"It looks like antioxidant supplements in general ... have no value of their own" and may actually interfere with cholesterol drugs' ability to boost HDL, said Dr. B. Greg Brown of the University of Washington at Seattle, one of the researchers.

The one-year study was published in the August issue of Atherosclerosis, Thrombosis and Vascular Biology, a journal of the American Heart Association. It involved 153 patients ages 33 to 74 who had heart disease and high LDL levels.

The patients were randomly assigned to one of four treatment groups: drug therapy with Zocor and niacin; a combination of the antioxidant vitamins E, C and beta carotene plus selenium; drug therapy and the antioxidant supplements; or a placebo.

The patients receiving antioxidants and drugs had an average HDL increase of 18 percent, compared with 25 percent among those who received drugs alone. HDL remained unchanged with vitamins alone or the placebo.

A component of HDL cholesterol called HDL(2), which is thought to account for much of HDL's benefit, was especially affected. Its levels increased by 42 percent with drugs alone but remained unchanged in patients who also received antioxidants.

In an editorial, Dr. Lewis H. Kuller of University of Pittsburgh said the results, along with other disappointing findings about vitamins, make a compelling case against recommending antioxidant supplements to prevent or treat coronary artery disease.

"It will be important that physicians advise their patients that the use of antioxidants could be hazardous," he said.

But Dr. Kenny Jialal of the University of Texas Southwestern Medical Center at Dallas criticized the study's small size and disagreed with the conclusion that patients should be warned off antioxidants.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext